ALknee Follow-up Study of the Cementless ATTUNE Rotating Platform and the Cementless LCS Rotating Platform Knee System

Sponsor
Spaarne Gasthuis (Other)
Overall Status
Recruiting
CT.gov ID
NCT05623215
Collaborator
Leiden University Medical Center (Other)
52
1
82.7
0.6

Study Details

Study Description

Brief Summary

The cementless ATTUNETM Rotating Platform Knee system was compared in a single-blind, randomized RSA trial to its predecessor, the LCS rotating platform Knee System. In this previous study, 61 knees were subjected to RSA examinations at 1-day and 3, 6, 12 and 24 months postoperative. This study found a promising equal migration of both tibial components and a lesser migration of the femoral component of the ATTUNETM knee system after two years, although with a similar migration rate between year 1 and 2. this raises the question of whether the migration of the prostheses relative to each other will increase or remain the same in the long term. To examine this, a mid-and long-term RSA follow-up to measure migration is necessary. In addition, another new RSA measurement parameter has become known in recent years that may provide an indication of the bonding of the prosthesis to the bone at the time of measurement. This new parameter, called the Induced Displacement (ID) of a prosthesis, measures the position and orientation relative to the bone while the prosthesis is under different loading conditions (e.g., patient in supine or standing position). This means that a large measured difference between these different loading condition measurements would indicate that osseointegration of the prosthesis never occurred or is no longer present. To improve the understanding of the tendency of both prostheses to aseptic loosening after a mid- to long-term follow up, migration over time and inducible displacement analyses are necessary.

The primary objective of this study is to accurately compare mid- and long-term migration of two uncemented TKR prostheses. The secondary objectives of this study are to evaluate if inducible displacement can be used as a parameter to detect loose implants, and to compare inducible displacement, clinical and radiological outcome and patient-reported outcomes (PROMS) after a follow-up of 5 and 10 years of two uncemented TKR prostheses.

Condition or Disease Intervention/Treatment Phase
  • Radiation: Radiographs of the knee for radiostereometric analysis (RSA)

Study Design

Study Type:
Observational
Anticipated Enrollment :
52 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Comparing the Migration and Inducible Displacement Through RSA of the Cementless ATTUNE Rotating Platform and the Cementless LCS Rotating Platform Knee System; A Clinical Randomized Controlled RSA Follow-up Study
Actual Study Start Date :
Nov 10, 2022
Anticipated Primary Completion Date :
May 1, 2029
Anticipated Study Completion Date :
Oct 1, 2029

Arms and Interventions

Arm Intervention/Treatment
Cementless ATTUNE

Cementless ATTUNE Rotating Platform Cruciate Sacrificing Knee System

Radiation: Radiographs of the knee for radiostereometric analysis (RSA)
RSA radiographs will be made 5 and 10 years after the total knee arthroplasty.

Cementless LCS

Cementless LCS rotating platform Cruciate Sacrificing Knee System

Radiation: Radiographs of the knee for radiostereometric analysis (RSA)
RSA radiographs will be made 5 and 10 years after the total knee arthroplasty.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline migration of the prostheses [5 years post TKA]

    Migration is measured and expressed in translations, rotations, and MTPM; MTPM is the point of the prosthesis that has moved most.

  2. Ten year change from baseline migration of the prostheses [10 years post TKA]

    Migration is measured and expressed in translations, rotations and MTPM; MTPM is the point of the prosthesis that has moved most.

Secondary Outcome Measures

  1. Inducible displacement [5 years post TKA]

    The inducible displacement is defined as the difference in translation (MTPM) between a measurement without external force (e.g., supine position) and a measurement with external force (e.g., weight bearing) minus the measurement error.

  2. Inducible displacement [10 years post TKA]

    The inducible displacement is defined as the difference in translation (MTPM) between a measurement without external force (e.g., supine position) and a measurement with external force (e.g., weight bearing) minus the measurement error.

  3. EuroQol 5D-5L (EQ-5D-5L) [5 year post TKA]

    A patient reported outcome score for assessing mental well-being by using a score from 0 to 1, with 0 = worse and 1 = best.

  4. EuroQol 5D-5L (EQ-5D-5L) [10 year post TKA]

    A patient reported outcome score for assessing mental well-being by using a score from 0 to 1, with 0 = worse and 1 = best.

  5. Knee injury and Osteoarthritis Outcome Scale Physical Function Short-form (KOOS-PS) [5 year post TKA]

    A 7-item patient reported outcome score that measures daily physical functioning by using a score of 0 to 100, with 0 = no problems and 100 = extreme problems.

  6. Knee injury and Osteoarthritis Outcome Scale Physical Function Short-form (KOOS-PS) [10 year post TKA]

    A 7-item patient reported outcome score that measures daily physical functioning by using a score of 0 to 100, with 0 = no problems and 100 = extreme problems.

  7. Oxford-12 Knee Score (OKS) [5 year post TKA]

    A 12-item patient-reported outcome score to assess function and pain after total knee arthroplasty. The score uses a score of 0 to 48, with 0 = worse and 48 = best.

  8. Oxford-12 Knee Score (OKS) [10 year post TKA]

    A 12-item patient-reported outcome score to assess function and pain after total knee arthroplasty. The score uses a score of 0 to 48, with 0 = worse and 48 = best.

  9. Kujala Anterior Knee Pain Scale (AKPS) [5 year post TKA]

    A 13-item patient reported outcome score for assessing daily anterior knee pain, by using a score from 0 to 100, with 0 = having anterior knee pain with disabilities and 100 = no signs of anterior knee pain.

  10. Kujala Anterior Knee Pain Scale (AKPS) [10 year post TKA]

    A 13-item patient reported outcome score for assessing daily anterior knee pain, by using a score from 0 to 100, with 0 = having anterior knee pain with disabilities and 100 = no signs of anterior knee pain.

  11. Numeric Rating Scale (NRS) [5 year post TKA]

    A patient reported outcome score for assessing pain by using a likert scale from 0 to 10, with 0 = no pain and 10 = severe pain)

  12. Numeric Rating Scale (NRS) [10 year post TKA]

    A patient reported outcome score for assessing pain by using a likert scale from 0 to 10, with 0 = no pain and 10 = severe pain)

  13. Anchor questions [5 year post TKA]

    A patient reported outcome score for assessing change in functioning and pain since surgery. The outcome is evaluated by use of a likert scale from 1 to 7, with 1 = much deteriorated and 7 = much improved).

  14. Anchor questions [10 year post TKA]

    A patient reported outcome score for assessing change in functioning and pain since surgery. The outcome is evaluated by use of a likert scale from 1 to 7, with 1 = much deteriorated and 7 = much improved).

Other Outcome Measures

  1. Complications [5 year post TKA]

    Complications during follow-up will be reported

  2. Complications [10 year post TKA]

    Complications during follow-up will be reported

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

In order to be eligible to participate in this study, a subject must meet all of the following criteria:

  • The Patient participated in the initial study (NL58911.058.16) [1].

  • The patient is capable of giving informed consent and expressing a willingness to comply with the study.

Exclusion Criteria:

A potential subject who meets any of the following criteria will be excluded from participation in this study:

  • The patient underwent a major revision TKR (exchange of the tibial or femoral component).

  • The patient is unable or unwilling to sign the informed consent specific to this study.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Spaarne Gasthuis Hoofddorp Noord-Holland Netherlands 2134TM

Sponsors and Collaborators

  • Spaarne Gasthuis
  • Leiden University Medical Center

Investigators

  • Principal Investigator: Peter A. Nolte, Prof. MD, Spaarne Gasthuis

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Spaarne Gasthuis
ClinicalTrials.gov Identifier:
NCT05623215
Other Study ID Numbers:
  • NL82000.058.22
First Posted:
Nov 21, 2022
Last Update Posted:
Nov 21, 2022
Last Verified:
Nov 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 21, 2022